Barinthus Biotherapeutics (BRNS) Return on Sales [ROS] (2020 - 2025)
Barinthus Biotherapeutics' Return on Sales [ROS] came in at -471.34% for Q4 2025, down 17.27 percentage points from -454.07% a year earlier but up 79.00 percentage points from the prior quarter.
Powered by 
Analysis
Barinthus Biotherapeutics (BRNS) Return on Sales [ROS] (2020 - 2025) Analysis & Trends
For FY2024, Barinthus Biotherapeutics' Return on Sales [ROS] was -454.07%, up 10009.02 percentage points from FY2023.
- Return on Sales [ROS] carries a four-year change of -38.27 percentage points (FY2020 to FY2024).
- Going back by year, Return on Sales [ROS] was -10463.09% in FY2023 (-10454.05 pp), -9.04% in FY2022 (+16864.47 pp), -16873.51% in FY2021 (-16457.70 pp) and -415.81% in FY2020.
- The five-year range for quarterly Return on Sales [ROS] is -48128.57% (Q2 2021) to 117.37% (Q3 2022).
- Year-over-year, Return on Sales [ROS] increased in two of the last five quarters, with an average year-over-year change of -1699.47 percentage points.
- The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2022 (a gain of 48206.14 percentage points), and the weakest in Q2 2021 (a drop of 47280.04 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Barinthus Biotherapeutics | 30.23 Mn | 30.29 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -471.34% |
| Sep 30, 2025 | -550.34% |
| Dec 31, 2024 | -454.07% |
| Sep 30, 2024 | -62.66% |
| Mar 31, 2024 | -23,755.69% |
| Dec 31, 2023 | -10,463.09% |
| Sep 30, 2023 | -1,226.33% |
| Jun 30, 2023 | -7,885.33% |
| Mar 31, 2023 | -4,590.60% |
| Dec 31, 2022 | -388.62% |
| Sep 30, 2022 | 117.37% |
| Jun 30, 2022 | 77.57% |
| Mar 31, 2022 | 4.35% |
| Dec 31, 2021 | -16,873.51% |
| Sep 30, 2021 | -29,136.84% |
| Jun 30, 2021 | -48,128.57% |
| Mar 31, 2021 | -2,870.70% |
| Dec 31, 2020 | -2,721.19% |
| Sep 30, 2020 | -43.92% |
| Jun 30, 2020 | -848.53% |
API Access
Barinthus Biotherapeutics Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BRNS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "BRNS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BRNS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();